Newswise — ARLINGTON, VA. (August 16, 2016)–Christopher R. McCurdy, Ph.D., R.Ph., FAAPS, of the University of Mississippi, has been elected to serve as president-elect of the American Association of Pharmaceutical Scientists (AAPS), a professional member-based organization of approximately 9,000 located in Arlington, VA. He will begin a three-year term on the AAPS Executive Council (as president-elect, president, and immediate past president) in November of this year at the 2016 AAPS Annual Meeting and Exposition in Denver. The meeting anticipates an attendance of over 7,000 pharmaceutical scientists from around the world.
“Christopher R. McCurdy will truly be an asset as president-elect of the association,” said Walt Marlowe, CAE, executive director of AAPS. “He is a proven leader that will move the strategic plan forward to best serve member needs. I know we’re all looking forward to working with Chris as president-elect.”
Dr. McCurdy noted in his election bulletin, “Having been a highly-involved member of AAPS over the last 15 years, I have a strong desire to continue supporting the organization that I feel is the most important to the interests of pharmaceutical scientists and educators. As president-elect, continued support and implementation of the new strategic plan, in order to guide the organization to greater heights and strength, is of highest importance."
In addition to the new president-elect, Annette Bak, Ph.D., M.B.A., AstraZeneca, and Bernd W. Meibohm, Ph.D., F.C.P., FAAPS, the University of Tennessee Health Science Center, were elected AAPS Members-at-Large. They join fellow Members-at-Large Robert L. Chapman, Ph.D., Joseph W. Polli, Ph.D., FAAPS, Stacey J. Tannenbaum, Ph.D., Treasurer William E. Weiser, Ph.D., President Binodh S. DeSilva, Ph.D., and Immediate Past President Gregory E. Amidon, Ph.D. as the remaining members on the 2016 AAPS Executive Council.
AAPS Section Leadership
AAPS members are organized into nine sections guided by scientific disciplines. These sections have also named their newest leaders:
Analysis and Pharmaceutical Quality (APQ) Section Secretary/Treasurer Anita L. Freed, Ph.D. Pfizer Inc.
Biotechnology (BIOTEC) Section Vice Chair Tarik Khan, Ph.D. F. Hoffmann-La Roche Ltd.
Clinical Pharmacology and Translational Research (CPTR) Section Vice ChairCatherine M.T. Sherwin, Ph.D., F.C.P. University of Utah
Drug Discovery and Development Interface (DDDI) Section Vice Chair Daniel R. Mudra, Ph.D. Eli Lilly and Company
Formulation Design and Development (FDD) Section Secretary/Treasurer Siladitya Ray Chaudhuri, Ph.D. Johnson & Johnson Research & Development
Manufacturing Science and Engineering (MSE) Section Secretary/Treasurer Carl Allenspach Bristol Myers Squibb Company
Physical Pharmacy and Biopharmaceutics (PPB) Section Secretary/Treasurer Balvinder S. Vig, Ph.D. Bristol-Myers Squibb Company
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism (PPDM) Section Vice Chair Swati Nagar, Ph.D. Temple University School of Pharmacy
Regulatory Sciences (RS) Section Secretary/Treasurer Barbara M. Davit, Ph.D., J.D. Merck Research Laboratories
RSS